{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "alpha-synuclein",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "alpha-synuclein Wt"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper defines that Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions the association of α-syn with PD, suggesting that changes in its function could contribute to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the ability of cytosolic factors to regulate α-syn binding to synaptic membranes, which is relevant to understanding the cellular localization and regulation of α-syn in neurons.",
          "judgment": "Yes",
          "reasoning": "The assay used in this study (investigating α-syn binding to synaptic membranes) models or reflects the disease pathogenesis/mechanism defined in Step 1 by examining the regulation of α-syn, a key protein in PD."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_number": "3a",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not explicitly stated"
                }
              ]
            },
            {
              "sub_step_number": "3b",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been: a) Broadly accepted historically (e.g., standard technique in the field)? OR b) Previously validated in other studies (cited)? OR c) Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "3c",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "4a",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant? (OddsPath refers to a quantitative measure of pathogenicity likelihood from functional assays)",
                  "answer": "Not explicitly stated"
                }
              ]
            },
            {
              "sub_step_number": "4b",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "4c",
              "questions": [
                {
                  "question": "Was an OddsPath value calculated in the paper for this variant?",
                  "answer": "Not explicitly stated"
                }
              ]
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "alpha-synuclein",
        "Protein_Change": {
          "ref": "",
          "alt": "α-syn mutant",
          "position": ""
        },
        "variant_string_id": "alpha-synuclein α-syn mutant"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper defines that Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The mutant α-syn is being compared to the wild-type, suggesting that changes in its function could contribute to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the ability of cytosolic factors to regulate α-syn binding to synaptic membranes, which is relevant to understanding the cellular localization and regulation of α-syn in neurons.",
          "judgment": "Yes",
          "reasoning": "The assay used in this study (investigating α-syn binding to synaptic membranes) models or reflects the disease pathogenesis/mechanism defined in Step 1 by examining the regulation of α-syn, a key protein in PD."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_number": "3a",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not explicitly stated"
                }
              ]
            },
            {
              "sub_step_number": "3b",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been: a) Broadly accepted historically (e.g., standard technique in the field)? OR b) Previously validated in other studies (cited)? OR c) Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "3c",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "4a",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant? (OddsPath refers to a quantitative measure of pathogenicity likelihood from functional assays)",
                  "answer": "Not explicitly stated"
                }
              ]
            },
            {
              "sub_step_number": "4b",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not applicable"
                }
              ]
            },
            {
              "sub_step_number": "4c",
              "questions": [
                {
                  "question": "Was an OddsPath value calculated in the paper for this variant?",
                  "answer": "Not explicitly stated"
                }
              ]
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    }
  ]
}